AgeX Therapeutics, Inc. (AGE)
NYSEAMERICAN: AGE · IEX Real-Time Price · USD
0.703 -0.018 (-2.43%)
Nov 29, 2021 12:27 PM EST - Market open
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | 2018 |
|---|---|---|---|
| Market Capitalization | 57 | 69 | 107 |
| Market Cap Growth | -16.39% | -36.04% | - |
| Enterprise Value | 63 | 68 | 100 |
| PE Ratio | -5.27 | -5.64 | -14.28 |
| PS Ratio | 30.67 | 39.65 | 76.74 |
| PB Ratio | -11.20 | 30.89 | 14.39 |
| P/FCF Ratio | -7.31 | -6.34 | -13.36 |
| P/OCF Ratio | -7.33 | -6.74 | -13.40 |
| EV/Sales Ratio | 33.03 | 37.91 | 70.47 |
| EV/EBITDA Ratio | -6.98 | -5.91 | -14.12 |
| EV/EBIT Ratio | -5.87 | -5.44 | -13.11 |
| EV/FCF Ratio | -7.87 | -6.06 | -12.27 |
| Debt / Equity Ratio | -1.23 | 0.88 | - |
| Debt / EBITDA Ratio | -0.71 | -0.18 | - |
| Debt / FCF Ratio | -0.80 | -0.18 | - |
| Current Ratio | 0.43 | 1.23 | 3.22 |
| Asset Turnover | 0.42 | 0.18 | 0.14 |
| Return on Equity (ROE) | 363.70% | -214.90% | -101.90% |
| Return on Assets (ROA) | -241.80% | -127.30% | -73.90% |
| Return on Capital (ROIC) | -853.90% | -10697.80% | 709.40% |
| Earnings Yield | -18.97% | -17.74% | -7.00% |
| FCF Yield | -13.68% | -15.76% | -7.48% |
| Buyback Yield / Dilution | -1.07% | -6.75% | -13.93% |
| Total Shareholder Return | -1.07% | -6.75% | -13.93% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).